Application of Fluorescence Dye in Combination with Methylene Blue for Axillary Reverse Mapping in Patients with Modified Radical Mastectomy for Breast Cancer

Table 1

Clinicopathological characteristics of patients.

Characteristics	Methylene blue+ICG (24)	Methylene blue (22)		Characteristics	Methylene blue+ICG (24)	Methylene blue (22)
Median age	48 (34~77)	51 (37~68)
HER2			0.375	Estrogen receptor status			0.072
Negative	15	10		Negative	12	5
Positive	9	12		Positive	12	17
Histologic type			0.987	Progesterone receptor status			0.085
Invasive ductal	15	15		Negative	14	7
Invasive lobular	5	6		Positive	10	15
Mix	4	1		P53			0.139
Clinical staging			0.421	Negative	9	4
I	0	3		Positive	6	11
II	11	11		VEGF			0.433
III	3	1		Negative	3	6
IV	0	0		Positive	12	10
I~II	3	2		E-cad			1
II~III	7	5		Negative	0	1
Topo II			0.484	Positive	16	15
Negative	1	0		Clinical T stage			0.285
Positive	14	16		T1	13	7
GST-π				T2	11	12
Negative	6	7	0.92	T3	0	1
Positive	9	9		Clinical N stage			0.64
p170				N0	10	10
Negative	10	9		N1	10	6
Positive	5	7	0.716	N2	3	2
Ki67 score				N3	1	3
<30%	7	12
30%~70%	13	8
70%<	4	2	0.259